Clovis Oncology, Inc. (CLVSQ) vs Vyome Holdings, Inc. (HIND)
Clovis Oncology, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Clovis Oncology, Inc. and Vyome Holdings, Inc. are of similar size ($14.5M and $14.2M). Clovis Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Vyome Holdings, Inc. grew revenue faster over the last twelve months: 103.8% against −14.8%. Clovis Oncology, Inc. has the higher net margin (−189.4% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Clovis Oncology, Inc. leads on 11 and Vyome Holdings, Inc. on 5.
Valuation
Profitability
| Metric | CLVSQ | HIND | Biotechnology median |
|---|---|---|---|
| Gross margin | 72.21% | 52.77% | 65.16% |
| Operating margin | (155.38%) | (9,184.82%) | 0.00% |
| Net margin | (189.37%) | (8,711.71%) | 0.00% |
| Free cash flow margin | (132.19%) | (4,298.00%) | 0.00% |
| Return on equity | 78.31% | (172.10%) | (57.72%) |
| Return on assets | (58.94%) | (124.23%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack